Temporomandibular joint disorders (TMD) constitutes of a group of diseases that functionally affect the masticatory system, including the muscles of mastication and temporomandibular joint (TMJ). A number of etiologies with specific treatment have been identified, including the transcutaneous electrical nerve stimulation (TENS). The current paper presents a literature review on the use of TENS in the management of TMD patients.
INTRODUCTION
Temporomandibular joint disorders (TMD) constitutes of a group of diseases or disorders that mainly affect the masticatory system, particularly the temporomandibular joint (TMJ) and related structures. 1 Majority of the people (approximately 75%) have been reported to have TMD signs and symptoms, with more than quarter (33%) having at least one symptom. 2 However, only a fraction of population has serious enough problem to seek clinical treatment. Temporomandibular joint disorder patients present with a number of signs and symptoms, including pain, malocclusion, altered joint function with or without deviation, clicking and/or restricted movement. 3 In addition, these patients may suffer from headache, tinnitus, altered vision, and other neurologic sings and symptoms might likewise go with TMD. 4 Patients with chronic TMD have also reported to present with signs and symptoms of depression, insomnia and low self-confidence.
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The etiology of TMD is multifactorial with no special or individual source. Factors that may initiate or disseminate the disorder include malocclusion, muscle hyperactivity, trauma, emotional stress. 6 Factors related to occlusion have been widely researched in recent years leading to increased use of occlusal splints and orthodontic treatment. 7 However, epidemiological data and systematic reviews have found poor or inexistent association of occlusion and TMD is poor or inexistent.
Academy of Orofacial Pain (AAOP) and Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) are the ones that are widely used. 8 Various treatment modalities have shown to be effective in reducing pain and restoring function of the masticatory system. 9 Transcutaneous electrical nerve stimulation (TENS) is one such treatment modality that merits unique consideration. Transcutaneous electrical nerve stimulation is not only safe to use but also result in reduced pain and electromyographic (EMG) activity of muscles of mastication. There are a few studies on the effectiveness of TENS therapy. [10] [11] [12] [13] This study is a literature review on the role of TENS in the management of TMD.
MATERIALS AND METHODS
To find relevant and adequate articles for the literature review, a detailed automated search of Cochrane, MED-LINE and PubMed databases was conducted from Jan 1, 1966, through March, 17, 2014. A combination of the following keywords was used: 'Temporomandibular disorder', 'trigger points', 'TENS', 'transcutaneous electrical nerve stimulation', and 'orofacial pain'. Review articles were also searched for additional articles missed in the automated searches. Experimental studies, review articles, letters to the editor, unpublished data and articles not published in English were excluded.
DISCUSSION
Transcutaneous electrical nerve stimulation therapy is fundamentally the utilization of a device managing low voltage, pulsed electrical current as a two-phase, symmetric or asymmetric wave, adjusted as a positive square semi-wave and a negative peak. Electrodes are connected to the skin surface aimed to unwind hyperactive muscles and alleviate pain. 14 A number of TENS devices are available in the market, however, there is a lack of standardization mechanism. Transcutaneous electrical nerve stimulation is a cost-effective, safe and noninvasive treatment modality for a number of painful conditions. 15 Electrodes may be silicone based that either gel application mechanism or self-adhesive. They are placed at the origin of pain or close to the site of highest pain, within the same dermatome, myotome and/or myofacial trigger points. They can also be placed on the pathway of peripheral nerves to further reduce pain and/or maintain the pain-free setting.
Transcutaneous electrical nerve stimulation devices are classified into two groups on the basis of pulse frequencies: high frequency (> 50 Hz) and low frequency (< 10 Hz). Devices that are used in the dental settings are generally mixed, with both low and high frequency currents. High frequency (50-150 Hz) devices have low intensity and have more centralized mechanism of action aimed at relieving long-lasting pain. Devices that have low frequency are generally specified for muscle relaxation as they essentially have peripheral mechanism of action. Intensity of the devices can be adjusted according to patients' sensitivity, to avoid muscle contractions and to achieve hypoesthesia or paresthesia of the affected area. Studies have shown intensities of 10 to 30 milliamps to be appropriate, resulting in few fasciculations. Further, pulse times between 40 and 75 microseconds are found to be effective.
In dentistry, TENS is mainly used to manage longlasting pain in certain cases and relax masticatory muscles. 16, 17 Studies have shown that at rest, patients suffering from muscular TMD have higher myoelectric activity of jaw elevator muscles than control group. 10 It is hypothesized that this increase myoelectric activity is due to sensory-motor interactions of craniofacial segment, resulting in modification in action potentials generations and, ultimately, myoelectric amplitude. Transcutaneous electrical nerve stimulation has been used to reduce the myoelectric activity in the anterior portion of these muscles along with pain relief. The useful effects of TENS are explained by different theories. One theory is that TENS directly stimulates the motor nerves resulting in rhythmic contractions of the masticatory muscles. This causes increased blood flow and oxygen to the muscles, and decreased interstitial edema and build up of harmful toxins. The overall result is decreased pain and fatigue of masticatory muscles. 18 Another theory, called the gate of pain theory was presented in 1965 to explain the electroanalgesia. 18 According to the theory, dorsal horn of the spinal cord contains a gate that controls the nociceptive entrance through small diameter afferent nerves. Tactile or pressure stimulation through electric impulses on large diameter peripheral afferents may result in inhibition of sensory neuron stimulations to spinal and supraspinal structures, effectively closing the gate. So, TENS would have both central and peripheral mechanisms of action.
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Transcutaneous electrical nerve stimulation have been reported to be effective as a treatment modality for TMD, both individually or in combination with other modalities. A pilot study was conducted to evaluate the electromyographic biofeedback and TENS in patients suffering from bruxism. 20 The authors concluded that although both therapies resulted in relaxation of muscles of mastication, TENS was more effective in decreasing the electromyographic activity of the masseter muscle. Another study reported that TENS together with interocclusion devices (IOD) resulted in a new spatial position of the jaw. 21 This new occlusion significantly improved the bite quality and strength, increased the efficiency of most evaluated muscle (p < 0.05) and reduced the pain. In a study, TENS was used in combination with occlusal splints and TENS to treat patients suffering from TMD and bruxism. 22 The authors concluded that both treatment modalities were insignificant in improving signs and symptoms in TMD patients. However, other studies have reported usefulness of occlusal splints in bruxism 23 and non-bruxism 24 patients. In one study,
authors assessed the influence of TENS combined with occlusal splint and physical therapy on craniomandibular disorders. They concluded that majority of the patients (83%) showed a significant decrease in signs and symptoms of craniomandibular disorders following 6 weeks of use of the treatment modalities.
CONCLUSION
Transcutaneous electrical nerve stimulation is an alternate treatment option for patients suffering from TMD. However, inconsistent nature of TMD patients necessitates randomized controlled studies in specific populations to categorize patients and diseases response. Furthermore, it is also important to identify facial pain syndromes that may benefit from adjuvant TENS therapy. At present, the utilization of TENS for the most part relies on upon clinical experience and its handling by health professionals.
